Enorama Pharma AB (publ)
STO: ERMA.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Bengt Jönsson
- Employees
- 5
- Headquarters
- Malmö, Sweden
- IPO year
- 2016
- Market cap
- SEK 19.8M
- Website
- https://www.enorama.se
Loading ERMA…
Loading profile data…Frequently asked questions about ERMA
What does Enorama Pharma AB (publ) (ERMA.ST) do?
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and all...
Where does ERMA.ST trade?
Enorama Pharma AB (publ) (ERMA.ST) trades on the Stockholm Stock Exchange.
What sector is ERMA.ST in?
Enorama Pharma AB (publ) (ERMA.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Enorama Pharma AB (publ)?
Bengt Jönsson is the chief executive officer of Enorama Pharma AB (publ) (ERMA.ST).
Where is Enorama Pharma AB (publ) headquartered?
Enorama Pharma AB (publ) is headquartered in Sweden.
Does ERMA.ST pay a dividend?
Enorama Pharma AB (publ) (ERMA.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ERMA.ST go public?
Enorama Pharma AB (publ) (ERMA.ST) completed its initial public offering in 2016.